Skip to content

Clinical trials

Thromboembolism trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: China Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20041
20061
20081
20091
20101
20121
20131
20142
20191
20201
20212
20221
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting4
Unknown status4
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Beijing Chao Yang Hospital3
Boehringer Ingelheim2
Beijing Anzhen Hospital1
Beijing Tiantan Hospital1
Beijing Tsinghua Chang Gung Hospital1
China-Japan Friendship Hospital1
Daiichi Sankyo1
First People's Hospital of Hangzhou1
Fu Wai Hospital, Beijing, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism23
Pulmonary Embolism5
Thrombosis3
Venous Thromboembolism3
Atrial Fibrillation2
Hemorrhage2
Ischemic Attack, Transient2
Stroke2
Venous Thrombosis2
Cerebrovascular Disorders1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.